Dr. Victor Chiu , MD
Internal Medicine - Hematology & Oncology • Mesa, AZ
6111 E Arbor Ave
Mesa, AZ 852066059
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Victor Chiu is listed in NPPES under Internal Medicine - Hematology & Oncology.
-
NPI assigned on May 7, 2010; this date does not establish years in practice.
-
Published CMS data list 68,978 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1439 — Injection, ferric carboxymaltose, 1 mg: 48,000 service units.
- Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml: 10,475 service units.
- J1453 — Injection, fosaprepitant, 1 mg: 5,100 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 36 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 905 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Anastrozole — 208 prescription fills, including refills.
- Ondansetron Odt (Ondansetron) — 82 prescription fills, including refills.
- Eliquis (Apixaban) — 76 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 27 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 60% of clinicians listed under Internal Medicine - Hematology & Oncology in Mesa, AZ (2024, 14 clinicians with data). Median for this group: 55,300. Middle half: 12,684 to 83,231.
More Medicare Part B services than 80% of clinicians listed under Internal Medicine - Hematology & Oncology in Arizona (2024, 205 clinicians with data). Median for this group: 14,477. Middle half: 577 to 52,085.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 281 in 2020 to 68,978 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
6111 E Arbor Ave
Mesa, AZ 852066059
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Ironwood Physicians Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of California, Davis School Of Medicine
2012
What Public CMS Data Show
Internal Medicine - Hematology & Oncology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
547 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $420,123 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $327,623 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,669 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$924,821 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $4,042.10 across 65 records.
By nature of payment
- Consulting Fee: $2,680.00 across 1 record.
- Food and Beverage: $1,362.10 across 64 records.
Reporting-company totals (3 largest of 26)
- AstraZeneca Pharmaceuticals LP: $2,775.78 across 6 records.
- Pfizer Inc.: $171.52 across 9 records.
- Exelixis Inc.: $136.64 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
14 years (graduated 2012)
CMS Doctors and Clinicians data list 2012 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2010
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Chiu has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Chiu as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Mesa and Arizona
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 60% of clinicians listed under Internal Medicine - Hematology & Oncology in Mesa, AZ (2024, 14 clinicians with data). Median for this group: 55,300. Middle half: 12,684 to 83,231.
More Medicare Part B services than 80% of clinicians listed under Internal Medicine - Hematology & Oncology in Arizona (2024, 205 clinicians with data). Median for this group: 14,477. Middle half: 577 to 52,085.
Medicare-allowed amount
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Mesa, AZ (2024, 14 clinicians with data). Median for this group: $468,428. Middle half: $129,557 to $885,402.
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Arizona (2024, 205 clinicians with data). Median for this group: $217,915. Middle half: $61,247 to $1,121,168.
Paid by Medicare
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Mesa, AZ (2024, 14 clinicians with data). Median for this group: $367,892. Middle half: $99,319 to $697,216.
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Arizona (2024, 205 clinicians with data). Median for this group: $164,676. Middle half: $45,930 to $891,389.
Medicare Part D prescriptions
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Mesa, AZ (2024, 13 clinicians with data). Median for this group: 963. Middle half: 815 to 1,275.
More Part D prescriptions than 65% of clinicians listed under Internal Medicine - Hematology & Oncology in Arizona (2024, 216 clinicians with data). Median for this group: 507. Middle half: 215 to 1,080.
Part D drug cost
A lower Part D drug cost than 75% of clinicians listed under Internal Medicine - Hematology & Oncology in Mesa, AZ (2024, 13 clinicians with data). Median for this group: $2,166,688. Middle half: $924,821 to $2,973,556.
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Arizona (2024, 216 clinicians with data). Median for this group: $1,135,281. Middle half: $274,285 to $2,461,391.
16 active clinicians are listed under Internal Medicine - Hematology & Oncology with a practice address in Mesa, AZ (285 in Arizona).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Mesa
68.8% of these 16 clinicians have the CMS telehealth indicator.
87.5% of these 16 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 24447% from 281 in 2020 to 68,978 in 2024.
- 2020: 281
- 2021: 419
- 2022: 510
- 2023: 54,561
- 2024: 68,978
-
Medicare-allowed amount
Medicare-allowed amount increased 1724% from $23,036 in 2020 to $420,123 in 2024.
- 2020: $23,036
- 2021: $35,170
- 2022: $55,001
- 2023: $386,926
- 2024: $420,123
-
Paid by Medicare
Paid by Medicare increased 1692% from $18,282 in 2020 to $327,623 in 2024.
- 2020: $18,282
- 2021: $27,584
- 2022: $42,442
- 2023: $305,390
- 2024: $327,623
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 2562% from 34 in 2020 to 905 in 2024.
- 2020: 34
- 2021: 25
- 2022: 61
- 2023: 565
- 2024: 905
-
30-day fills
30-day fills increased 3846% from 42 in 2020 to 1,669 in 2024.
- 2020: 42
- 2021: 32
- 2022: 76
- 2023: 779
- 2024: 1,669
-
Part D drug cost
Part D drug cost went from $825 in 2020 to $924,821 in 2024.
- 2020: $825
- 2021: $250
- 2022: $10,453
- 2023: $456,769
- 2024: $924,821
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $36.63 in 2021 to $4,042.10 in 2025.
- 2021: $36.63
- 2022: $687.69
- 2023: $1,692.25
- 2024: $3,274.35
- 2025: $4,042.10
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 65 records totaling $4,042.10.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Consulting Fee
Cash or cash equivalent
|
DATROWAY | General | $2,680.00 |
| Exelixis Inc. |
Food and Beverage
In-kind items and services
|
CABOMETYX | General | $115.25 |
| Iovance Biotherapeutics, Inc. |
Food and Beverage
Cash or cash equivalent
|
Amtagvi | General | $37.47 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
Enhertu | General | $29.02 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
EPKINLY | General | $28.85 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
EPKINLY | General | $27.69 |
| Daiichi Sankyo Inc. |
Food and Beverage
In-kind items and services
|
Vanflyta | General | $27.59 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Fabhalta | General | $27.26 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
PEMAZYRE | General | $26.05 |
| Aveo Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
FOTIVDA | General | $24.69 |
| SpringWorks Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $24.41 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ENHERTU | General | $24.32 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
BOSULIF | General | $24.29 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELREXFIO | General | $24.16 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KISQALI | General | $24.09 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
ENHERTU | General | $24.05 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $23.43 |
| PUMA BIOTECHNOLOGY, INC. |
Food and Beverage
In-kind items and services
|
NERLYNX | General | $22.70 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
BRAFTOVI | General | $22.18 |
| Caris MPI, Inc. |
Food and Beverage
In-kind items and services
|
MI CANCER SEEK | General | $22.03 |
| SpringWorks Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
OGSIVEO | General | $21.83 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $21.75 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
BRAFTOVI | General | $21.43 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
SARCLISA | General | $21.42 |
| Stemline Therapeutics Inc. |
Food and Beverage
In-kind items and services
|
Orserdu | General | $21.40 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2018–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2019–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1439
Injection, ferric carboxymaltose, 1 mg
|
48,000 | 32 | $3.00 | $1.10 |
|
Q9967
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
|
10,475 | 96 | $1.00 | $0.13 |
|
J1453
Injection, fosaprepitant, 1 mg
|
5,100 | 11 | $3.00 | $0.14 |
|
J1100
Injection, dexamethasone sodium phosphate, 1 mg
|
1,342 | 30 | $1.00 | $0.11 |
|
J2469
Injection, palonosetron hcl, 25 mcg
|
860 | 25 | $6.00 | $0.89 |
|
J2405
Injection, ondansetron hydrochloride, per 1 mg
|
528 | 15 | $2.00 | $0.09 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
407 | 211 | $125.00 | $87.01 |
|
96367
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
|
271 | 36 | $60.00 | $27.20 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
263 | 124 | $182.00 | $122.69 |
|
96413
Administration of chemotherapy into vein, 1 hour or less
|
248 | 55 | $252.00 | $123.56 |
|
96372
Injection of drug or substance under skin or into muscle
|
147 | 47 | $78.00 | $13.80 |
|
J3489
Injection, zoledronic acid, 1 mg
|
117 | 14 | $20.00 | $6.54 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
101 | 101 | $280.00 | $159.69 |
|
A9552
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
|
97 | 80 | $951.00 | $353.14 |
|
96365
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
|
89 | 45 | $119.00 | $59.85 |
|
71260
Ct scan of chest with contrast
|
83 | 71 | $377.00 | $61.07 |
|
96417
Administration of additional new drug or substance into vein, 1 hour or less
|
78 | 21 | $125.00 | $60.91 |
|
J1200
Injection, diphenhydramine hcl, up to 50 mg
|
78 | 19 | $2.00 | $0.83 |
|
74177
Ct scan of abdomen and pelvis with contrast
|
76 | 65 | $400.00 | $216.11 |
|
96375
Injection of additional new drug or substance into vein
|
75 | 19 | $40.00 | $14.71 |
|
78815
Nuclear medicine study from skull base to mid-thigh with ct scan
|
71 | 58 | $3055.24 | $1446.49 |
|
J3490
Unclassified drugs
|
71 | 15 | $3.00 | $0.71 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
63 | 30 | $142.00 | $75.25 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
47 | 47 | $185.00 | $105.56 |
|
71250
Ct scan of chest without contrast
|
46 | 41 | $319.00 | $68.54 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Anastrozole | Anastrozole | 208 | 17,879 | $4,595.40 | 74 |
| Ondansetron Odt | Ondansetron | 82 | 1,506 | $1,323.93 | 55 |
| Eliquis | Apixaban | 76 | 4,069 | $79,965.41 | 25 |
| Prednisone | Prednisone | 56 | 1,183 | $156.33 | 21 |
| Levothyroxine Sodium | Levothyroxine Sodium | 41 | 2,130 | $578.49 | 14 |
| Hydroxyurea | Hydroxyurea | 40 | 2,733 | $851.43 | 11 |
| Dexamethasone | Dexamethasone | 31 | 468 | $652.53 | 21 |
| Exemestane | Exemestane | 30 | 2,370 | $4,225.26 | 13 |
| Abiraterone Acetate | Abiraterone Acetate | 30 | 900 | $25,973.48 | — |
| Xarelto | Rivaroxaban | 28 | 1,890 | $34,872.63 | 11 |
| Letrozole | Letrozole | 25 | 2,188 | $924.87 | 11 |
| Oxycodone Hcl | Oxycodone Hcl | 23 | 369 | $301.36 | 15 |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 23 | 625 | $425.47 | 17 |
| Olanzapine | Olanzapine | 23 | 630 | $336.90 | 12 |
| Acyclovir | Acyclovir | 21 | 1,430 | $429.93 | — |
| Trazodone Hcl | Trazodone Hcl | 20 | 600 | $79.96 | — |
| Lenalidomide | Lenalidomide | 18 | 504 | $270,862.37 | — |
| Alendronate Sodium | Alendronate Sodium | 14 | 1,218 | $181.55 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 14 | 720 | $93.50 | — |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 14 | 532 | $120.57 | — |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | 234 | $387.58 | — |
| Potassium Chloride | Potassium Chloride | 13 | 286 | $64.77 | — |
| Hydrocortisone | Hydrocortisone | 13 | 318 | $166.68 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 13 | 510 | $151.58 | — |
| Verzenio | Abemaciclib | 12 | 336 | $200,140.29 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-01-05NUCC Taxonomy Code: 207RH0003X
An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - HEMATOLOGY/ONCOLOGY
I20220513002409
AZ
2668789942
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Ironwood Physicians Pc
6111 E Arbor Ave, Mesa, AZ 852066059
Phone: 4809811326
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Surgery
Doctor of Medicine (M.D.)
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Radiology - Radiation Oncology
Obstetrics & Gynecology - Gynecologic Oncology
Doctor of Medicine (M.D.)
Surgery
Doctor of Osteopathic Medicine (D.O.)
Nurse Practitioner - Gerontology
Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Internal Medicine (license number reported to NPPES: AZ 65697)
Registered at 6111 E ARBOR AVE, MESA, AZ 852066059 (Tel: 4809811326)
Registered at PO BOX 6423, CHANDLER, AZ 852466423 (Tel: 4808552224)
Registered at 14445 OLIVE VIEW DR STE 2A157, SYLMAR, CA 913421437 (Tel: 7472103540)
Registered at 5767 W CENTURY BLVD STE 400, LOS ANGELES, CA 900455631
Internal Medicine (license number reported to NPPES: CA A127101)
NPI status registered as active in NPPES database
Registered at 4610 X ST, SACRAMENTO, CA 958172200 (Tel: 9167625351)
Registered at 4610 X ST, SACRAMENTO, CA 958172200 (Tel: 9167625351)
Recorded as VICTOR CHIU, M.D.
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Hematology & Oncology Specialists in Mesa
- Dr. Michael Long, MD
- Dr. Pranshu Bansal, MD
- Dr. Michael Musci, MD
- Dr. Neel Dharia, MD
- Dr. Manisha Chandar, DO
- Dr. Chad Cherington, MD
Mailing Address
Po Box 6423
Chandler, AZ 852466423